tirzepatide weight loss study outperformed semaglutide weight-loss drug results in real world patients, shows Can weight-loss pens really deliver

That might show up as a great result on the scale, but it leaves people metabolically weaker, not stronger

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Analysis of EHR notes for on-treatment functional features showed reduced exercise tolerance was the strongest correlate of greater LBM loss, increasing by 7.2 and 11.1 percentage points in semaglutide- and tirzepatide-treated patients, respectively

A group of doctors says GLP-1 weight loss drugs could harm vision.

Everything you need to know about Wegovy from the cost to who can prescribe the weight loss drug in UK.

This medication has been identified as Zepbound 15 mg/0.5 mL injection (single-dose vial) and is used for Obstructive Sleep Apnea/Hypopnea Syndrome, and Weight Loss.